{"id":43934,"date":"2025-10-09T18:14:28","date_gmt":"2025-10-09T18:14:28","guid":{"rendered":"https:\/\/popularnews.pw\/?page_id=43934"},"modified":"2025-10-09T18:14:28","modified_gmt":"2025-10-09T18:14:28","slug":"implement-sweeping-medicare","status":"publish","type":"page","link":"https:\/\/popularnews.pw\/?page_id=43934","title":{"rendered":"Implement Sweeping Medicare"},"content":{"rendered":"

Washington, D.C. \u2014<\/strong>\u00a0A renewed effort is underway in the United States to reduce the cost of prescription medications, as federal officials prepare to revisit a proposal that would align certain drug prices with the lower rates found in other developed countries.<\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n

According to individuals familiar with the matter, the proposal\u2014known as a \u201cmost favored nation\u201d pricing policy\u2014could be advanced through an executive order in the coming days. The initiative would apply to a selection of drugs covered under Medicare and aims to bring U.S. prices closer to those paid by other nations, where prescription medications often cost significantly less.<\/p>\n

<\/div>\n

The plan, still under internal review, is being shaped by senior administration officials and healthcare policy advisers. If finalized, it would represent a major shift in how the federal government negotiates\u2014or benchmarks\u2014the cost of medications purchased for millions of Americans.<\/p>\n

Renewed Focus on Healthcare Costs<\/h3>\n

While no official details have been confirmed, sources say the announcement could come early next week. In recent meetings, the President has hinted at an upcoming announcement related to healthcare, calling it \u201cvery big\u201d and \u201cone of the most important\u201d in recent years.<\/p>\n

<\/div>\n

This policy approach is not new. A similar version was first introduced several years ago but faced legal and regulatory obstacles that stalled its implementation. At the time, the plan encountered resistance from both pharmaceutical companies and legal experts who questioned the method of enforcement.<\/p>\n

Despite past hurdles, the rising cost of prescription drugs continues to be a pressing concern for many Americans, particularly older adults and individuals with chronic conditions. By tying U.S. prices to those charged in other countries, advocates of the proposal hope to create a more balanced and fair pricing system.<\/p>\n